Effect of an isoxsuprine-resin preparation on blood flow in the equine thoracic limb.

The research investigated the effects of a specific medication, isoxsuprine-resin, on blood flow in the limbs of horses, finding that this treatment increased skin temperatures, and by extension, blood flow.

Study Methodology

• The team tested the effects of an oral isoxsuprine-resin preparation on seven horses.
• The isoxsuprine’s effect on blood flow was measured using thermography, a technique used to detect changes in temperature, which can indicate changes in blood flow.
• Comparisons were made between the treated horses and non-medicated controls to observe the isoxsuprine’s effect.
• Two varying doses, 0.9 mg/kg and 1.2 mg/kg, were used to measure the treatment’s efficacy.

Main Findings

• Treatment with the oral resin preparation resulted in increased skin temperatures, indicating an increase in blood flow in comparison to the non-medicated control group.
• The maximal temperature differences, an increase of 2.2 degrees C for the 0.9 mg/kg dose and 1.8 degrees C for the 1.2 mg/kg dose, were observed four hours after medication was administrated.

Plasma Isoxsuprine Levels

• The study also analyzed plasma total isoxsuprine in three of the horses. It was found to be detectable two hours post-oral dosing, and reached its maximum levels eight hours after dosing.
• No free isoxsuprine, which is isoxsuprine not bound to proteins, could be detected in the tests. This suggests that all isoxsuprine introduced was bound to proteins in the body.

Receptor Binding Studies

• The research team conducted receptor binding studies on the treated horses which showed strong alpha-receptor binding by isoxsuprine.
• This binding was robust enough that it could have stimulated the receptors even at concentrations of isoxsuprine below the detection level.

Study Implications

• The findings of this study suggest that treatment with isoxsuprine-resin preparation promotes an increase in blood flow in the thoracic limb of horses, thus potentially having therapeutic use in improving circulation.
• The research also highlights the robust interaction of isoxsuprine with alpha-receptors increasing the potential efficacy of this treatment.